Nanoparticle-Macrophage Interactions Implications for Nanosafety and Nanomedicine
Nanoparticles (NPs) offer unique properties for biomedical applications, leading to new nanomedicines. Recent examples of advanced nanoparticle-based nanomedicines are COVID-19 RNA vaccines. Regardless of the delivery route of the NPs into the body (intravenous or subcutaneous injection, oral, intra...
Saved in:
Other Authors: | , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_93174 | ||
005 | 20221025 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20221025s2022 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-4600-1 | ||
020 | |a 9783036545998 | ||
020 | |a 9783036546001 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-4600-1 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
100 | 1 | |a Bondarenko, Olesja |4 edt | |
700 | 1 | |a Torres Andón, Fernando |4 edt | |
700 | 1 | |a Bondarenko, Olesja |4 oth | |
700 | 1 | |a Torres Andón, Fernando |4 oth | |
245 | 1 | 0 | |a Nanoparticle-Macrophage Interactions |b Implications for Nanosafety and Nanomedicine |
260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 electronic resource (208 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Nanoparticles (NPs) offer unique properties for biomedical applications, leading to new nanomedicines. Recent examples of advanced nanoparticle-based nanomedicines are COVID-19 RNA vaccines. Regardless of the delivery route of the NPs into the body (intravenous or subcutaneous injection, oral, intranasal, etc.), NPs inevitably come into contact with immune cells, such as macrophages. Macrophages are phagocytizing cells that determine the fate and the lifetime of NPs in relevant biological fluids or tissues, which has consequences for both nanosafety and nanomedicine. The aim of this Special Issue is to cover recent advancements in our understanding of NP-macrophage interactions, with a focus on in vitro models for nanosafety and novel nanomedicine approaches that allow the modulation of the immunological profile of macrophages. The current Special Issue compiles nine papers: seven research articles and two review articles. The original articles include studies on the interaction of different nanomaterials, such as multi-walled carbon nanotubes (MWCNTs), amorphous silica, gold nanoparticles, lipid carriers, and microspheres, with macrophages in different scenarios. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
653 | |a chronic wound | ||
653 | |a device | ||
653 | |a foot ulcer | ||
653 | |a inflammation | ||
653 | |a wound healing | ||
653 | |a macrophage | ||
653 | |a nanomaterial | ||
653 | |a nanoparticle | ||
653 | |a drug delivery | ||
653 | |a immune system | ||
653 | |a anti-inflammatory | ||
653 | |a innate immunity | ||
653 | |a osteoarthritis | ||
653 | |a rifabutin | ||
653 | |a nanostructured lipid carriers | ||
653 | |a cell uptake | ||
653 | |a Caco-2 cells | ||
653 | |a oral administration | ||
653 | |a Crohn's disease | ||
653 | |a nanomaterials | ||
653 | |a macrophages | ||
653 | |a class A type 1 scavenger receptors | ||
653 | |a cytotoxicity | ||
653 | |a macrophage-nanoparticle interaction | ||
653 | |a monocytes | ||
653 | |a gold nanoparticles | ||
653 | |a in vitro models | ||
653 | |a innate memory | ||
653 | |a 2D cultures | ||
653 | |a 3D cultures | ||
653 | |a carbon nanotube | ||
653 | |a scavenger receptor | ||
653 | |a phagocytosis | ||
653 | |a protein corona | ||
653 | |a bovine serum albumin | ||
653 | |a synthetic amorphous silica | ||
653 | |a in vitro testing | ||
653 | |a NR8383 alveolar macrophage | ||
653 | |a ICP-MS analysis of cell bound SiO2 | ||
653 | |a multi-walled carbon nanotubes | ||
653 | |a nanoparticles | ||
653 | |a chemokines | ||
653 | |a transcriptomics | ||
653 | |a zebrafish | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/6070 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/93174 |7 0 |z DOAB: description of the publication |